249 related articles for article (PubMed ID: 16386908)
21. Design, synthesis, molecular modeling, and anti-HIV-1 integrase activity of a series of photoactivatable diketo acid-containing inhibitors as affinity probes.
Sechi M; Carta F; Sannia L; Dallocchio R; Dessì A; Al-Safi RI; Neamati N
Antiviral Res; 2009 Mar; 81(3):267-76. PubMed ID: 19135482
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological evaluation of novel hybrid dicaffeoyltartaric/diketo acid and tetrazole-substituted L-chicoric acid analogue inhibitors of human immunodeficiency virus type 1 integrase.
Crosby DC; Lei X; Gibbs CG; McDougall BR; Robinson WE; Reinecke MG
J Med Chem; 2010 Nov; 53(22):8161-75. PubMed ID: 20977258
[TBL] [Abstract][Full Text] [Related]
23. Ethyl malonate amides: a diketo acid offspring fragment for HIV integrase inhibition.
Serafin K; Mazur P; Bak A; Laine E; Tchertanov L; Mouscadet JF; Polanski J
Bioorg Med Chem; 2011 Aug; 19(16):5000-5. PubMed ID: 21767953
[TBL] [Abstract][Full Text] [Related]
24. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
Dayam R; Sanchez T; Clement O; Shoemaker R; Sei S; Neamati N
J Med Chem; 2005 Jan; 48(1):111-20. PubMed ID: 15634005
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester.
Wang P; Liu C; Sanches T; Zhong Y; Liu B; Xiong J; Neamati N; Zhao G
Bioorg Med Chem Lett; 2009 Aug; 19(16):4574-8. PubMed ID: 19625188
[TBL] [Abstract][Full Text] [Related]
26. A novel strategy to assemble the beta-diketo acid pharmacophore of HIV integrase inhibitors on purine nucleobase scaffolds.
Uchil V; Seo B; Nair V
J Org Chem; 2007 Oct; 72(22):8577-9. PubMed ID: 17918897
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors.
Patil S; Kamath S; Sanchez T; Neamati N; Schinazi RF; Buolamwini JK
Bioorg Med Chem; 2007 Feb; 15(3):1212-28. PubMed ID: 17158051
[TBL] [Abstract][Full Text] [Related]
28. Pharmacophore-based database mining for probing fragmental drug-likeness of diketo acid analogues.
Bak A; Magdziarz T; Polanski J
SAR QSAR Environ Res; 2012 Jan; 23(1-2):185-204. PubMed ID: 22292781
[TBL] [Abstract][Full Text] [Related]
29. Hydrazide-containing inhibitors of HIV-1 integrase.
Zhao H; Neamati N; Sunder S; Hong H; Wang S; Milne GW; Pommier Y; Burke TR
J Med Chem; 1997 Mar; 40(6):937-41. PubMed ID: 9083482
[TBL] [Abstract][Full Text] [Related]
30. Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities.
Di Santo R; Costi R; Roux A; Miele G; Crucitti GC; Iacovo A; Rosi F; Lavecchia A; Marinelli L; Di Giovanni C; Novellino E; Palmisano L; Andreotti M; Amici R; Galluzzo CM; Nencioni L; Palamara AT; Pommier Y; Marchand C
J Med Chem; 2008 Aug; 51(15):4744-50. PubMed ID: 18646746
[TBL] [Abstract][Full Text] [Related]
31. Design of novel bioisosteres of beta-diketo acid inhibitors of HIV-1 integrase.
Sechi M; Sannia L; Carta F; Palomba M; Dallocchio R; Dessì A; Derudas M; Zawahir Z; Neamati N
Antivir Chem Chemother; 2005; 16(1):41-61. PubMed ID: 15739621
[TBL] [Abstract][Full Text] [Related]
32. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
[TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.
Xue P; Lu HH; Zhu YY; Ju XL; Pannecouque C; Zheng XJ; Liu GY; Zhang XL; Gu SX
Bioorg Med Chem Lett; 2017 Apr; 27(8):1640-1643. PubMed ID: 28314598
[TBL] [Abstract][Full Text] [Related]
34. Benzyl amide-ketoacid inhibitors of HIV-integrase.
Walker MA; Johnson T; Naidu BN; Banville J; Remillard R; Plamondon S; Martel A; Li C; Torri A; Samanta H; Lin Z; Dicker I; Krystal M; Meanwell NA
Bioorg Med Chem Lett; 2007 Sep; 17(17):4886-90. PubMed ID: 17604626
[TBL] [Abstract][Full Text] [Related]
35. Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods.
Hu JP; He HQ; Tang DY; Sun GF; Zhang YQ; Fan J; Chang S
J Biomol Struct Dyn; 2013; 31(7):734-47. PubMed ID: 22913375
[TBL] [Abstract][Full Text] [Related]
36. HIV integrase inhibitors as therapeutic agents in AIDS.
Nair V; Chi G
Rev Med Virol; 2007; 17(4):277-95. PubMed ID: 17503547
[TBL] [Abstract][Full Text] [Related]
37. New developments in diketo-containing inhibitors of HIV-1 integrase.
Zhao G; Wang C; Liu C; Lou H
Mini Rev Med Chem; 2007 Jul; 7(7):707-25. PubMed ID: 17627583
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching.
Nicklaus MC; Neamati N; Hong H; Mazumder A; Sunder S; Chen J; Milne GW; Pommier Y
J Med Chem; 1997 Mar; 40(6):920-9. PubMed ID: 9083480
[TBL] [Abstract][Full Text] [Related]
39. Quinolone carboxylic acids as a novel monoketo acid class of human immunodeficiency virus type 1 integrase inhibitors.
Sato M; Kawakami H; Motomura T; Aramaki H; Matsuda T; Yamashita M; Ito Y; Matsuzaki Y; Yamataka K; Ikeda S; Shinkai H
J Med Chem; 2009 Aug; 52(15):4869-82. PubMed ID: 19719237
[TBL] [Abstract][Full Text] [Related]
40. Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.
Di Santo R; Costi R; Roux A; Artico M; Lavecchia A; Marinelli L; Novellino E; Palmisano L; Andreotti M; Amici R; Galluzzo CM; Nencioni L; Palamara AT; Pommier Y; Marchand C
J Med Chem; 2006 Mar; 49(6):1939-45. PubMed ID: 16539381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]